Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
The Netherlands Cancer Institute · University of California, Los Angeles · +4 more institutions
Indexed incrossrefdoajpubmed
Abstract
No abstract available for this paper.
Citation impact
633
total citations
- FWCI
- 16.50
- Percentile
- 100%
- References
- 56
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Microphthalmia-associated transcription factor
- Cancer research
- Melanoma
- Neuroblastoma RAS viral oncogene homolog
- Receptor tyrosine kinase
- Transcription factor
- Tyrosine kinase
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- ACAmerican Cancer SocietyAwards: UL1TR000124, RSG-12-257-01-TBE
- MRMelanoma Research AllianceAward: 20120279
- ULUniversiteit Leiden
- KKKWF Kankerbestrijding
- LULeids Universitair Medisch Centrum
- NINational Institutes of HealthAwards: UL1TR000124, P01 CA168585
- NCNational Center for Advancing Translational SciencesAward: UL1TR000124
- CAClinical and Translational Science Institute, University of California, Los AngelesAward: UL1TR000124